We are live on ! Find out more
TARO

Taro Pharmaceutical Industries Ltd.
TARO

Delisted

TARO was delisted on the 21st of June, 2024.

Back to rankings

1 hedge funds and large institutions have $3.27K invested in Taro Pharmaceutical Industries Ltd. in 2025 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

0% more capital invested

Capital invested by funds: $3.27K → $3.27K ($0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

TARO Hedge Fund Activity: Q3 2025 in Review

1 of the 7,638 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q3 2025, worth a combined $3.27K — unchanged from a quarter earlier.

Fund positioning in TARO was balanced in Q3 2025: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Taro Pharmaceutical Industries Ltd. (TARO) as of Q3 2025, unchanged from Q2 2025.
  • Funds reported $3.27K of Taro Pharmaceutical Industries Ltd. stock for Q3 2025, unchanged quarter-over-quarter.
  • 0 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q3 2025 and 0 closed out.

Based on aggregated 13F filings for Q3 2025.